England’s Health Service Does Deal With Novartis To Provide Kymriah For Relapsed Childhood Leukemia

The National Health Service in England will offer CAR T-cell therapy to children with leukemia after striking a discount deal with Novartis.

Read the full post on Forbes - Healthcare